Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2019-02-28 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Exercise or conversion · Restricted Stock Units −4,495 4,495
2019-02-28 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Exercise or conversion · Restricted Stock Units −2,798 5,595
2019-02-28 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Exercise or conversion · Restricted Stock Units −9,555 19,110
2019-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +2,990 5,252
2019-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +9,727 14,979
2019-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −2,990 5,980
2019-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −9,727 19,453
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +2,668 28,311
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +2,075 30,386
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +1,270 31,656
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +4,213 35,869
2019-02-28 Tessmer James F VP, Finance & Accounting Shares withheld for taxes −2,501 $5.51 $14K 33,368
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −2,668 0
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −2,075 2,075
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −1,270 2,540
2019-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −4,213 8,427
2019-02-28 Santini Alexander A EVP and CCO Exercise or conversion +2,352 7,649
2019-02-28 Santini Alexander A EVP and CCO Exercise or conversion +2,593 10,242
2019-02-28 Santini Alexander A EVP and CCO Exercise or conversion +8,463 18,705
2019-02-28 Santini Alexander A EVP and CCO Shares withheld for taxes −4,544 $5.51 $25K 14,161

Page 46 of 51 · 1,001 trades